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Aim. The aim of the study is to reveal molecular mechanisms of possible activity 
modulation of antimicrobial bisquaternary ammonium compounds (BQAC) and aspirin 
(ASP) through noncovalent competitive complexation under their combined introduction 
into the model systems with membrane phospholipids. Methods. Binary and triple 
systems containing either decamethoxinum or ethonium, or thionium and aspirin, as well 
as dipalmitoylphosphatidylcholine  (DPPC) have been investigated by electrospray 
ionization mass spectrometry. Results. Basing on the analysis of associates recorded in 
the mass spectra, the types of nonocovalent complexes formed in the systems studied 
were determined and the supposed role of the complexation in the BQAC and ASP 
activity modulation was discussed. The formation of associates of BQAC dications with 
ASP anion is considered as one of the possible ways of deactivation of ionic forms of the 
medications. The formation of stable complexes of BQAC with DPPC and ASP with 
DPPC in binary systems as well as the complexes distribution in triple-components 
systems BQAC:ASP:DPPC point to the existence of competition between drugs of these 
two types for the binding to DPPC. Conclusions. The results obtained point to the 
competitive complexation in the model molecular systems containing the BQAC, aspirin 
and membrane phospholipids. The observed phenomenon testifies to the possibility of 
modulating the activity of bisquaternary antimicrobial agents and aspirin under their 
combined usage, due to the competition between the drugs for binding to the target 
membrane phospholipid molecules and also due to the formation of stable noncovalent 
complexes between BQAC and ASP.  
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Introduction. Among urgent biomedical problems, the elucidation of either increase or 
decrease of the biological activity of several medicines at their combined use is of 
practical importance in connection with a high probability of mutual modulation of the 
medications activity in multi-drug therapeutic schemes of the modern medical practice. 
Along with tests on living organisms, model studies of the mechanisms of action of 
biologically active compounds at the molecular level permit to save time and resources 
prior to the experiments with real biological objects. Soft ionization mass spectrometry as 
an up-to-date method of molecular biophysics [1] is an efficient tool for studies of 
biomolecules and their intermolecular interactions [1–4]. Electrospray ionization (ESI) 
mass spectrometric technique based on spraying solutions of biomolecules in polar 
solvents is applied to modeling selective noncovalent intermolecular interactions of 
biologically active agents, medicines in particular, with their specific molecular targets 
[5–8]. In the framework of a problem of elucidation of molecular mechanisms of action 
of membranotropic antimicrobial agents we are developing an integrated approach to 
study of interactions of bisquaternary ammonium compounds (BQAC, Cat2+⋅ 2Cl–) with 
phospholi- pid assemblies which mimic the membranes of bacterial cells [9–13].  
 
In our previous studies on molecular mechanisms of action of widely used antimicrobial 
BQACs decamethoxinum and ethonium, a combined application of ESI mass 
spectrometry, differential scanning calorimetry (DSC), and computer modelling [9] 
allowed us to reveal the formation of stable supramolecular complexes of the drugs with 
membrane phospholipids. The formation of such complexes is a prerequisite for the drugs 
incorporation into membranes, which distorts functioning of bacterial cell and thereby 
causes either bacteriostatic or bactericidal effect [13].  
 
The background for addressing the above stated problem of investigation of combined 
action of several membranotropic and biologically active agents by means of mass 
spectrometry lies in an effect observed by us during characterization of BQACs by 
matrix-assisted laser desorption/ionization mass spectrometry [14]: substitution of 
inorganic Cl– counterion of BQAC salts by anions of organic acids, 2,5-
dihydrohybenzoic acid (a metabolite of aspirin) in particular, took place in a mixture. 
Since the formation of stable complexes of the compounds of basic and acidic types can 
affect and modulate the membranotropic activity of individual drugs [11], the above 
result stimulated us to expand the study of noncovalent interactions of BQACs with 
biologically significant organic acids. Among the compounds which can be administered 
together with BQAC antimicrobial agents for treatment of microbial infections, a popular 
anti-inflammatory remedy acetylsalicylic acid (aspirin, ASP), which possesses 
membranotropic properties as well [15], was selected.  
 
In the current investigation different scenarios of possible activity modulation through 
noncovalent complexation of three antimicrobial BQACs decamethoxinum, ethonium, 
and thionium with aspirin under their combined mixing with a membrane phospholipid 
dipalmitoylphosphatidylcholine (DPPC) were examined using ESI mass spectrometry.  
 
Materials and methods. Chemical structures of the objects of investigation are presented 
in the Scheme. Decamethoxinum (I), ethonium (II) and thionium (III) were synthesized in 
the Institute of Organic Chemistry of the National Academy of Sciences of Ukraine. Pure 
acetylsalicylic acid (aspirin) (IV) was obtained from the State Scientific Centre of 
Medications (Ukraine). Dipalmitoylphosphatidylcholine (V) was purchased from ALSI 
(Ukraine). Methanol (Super grade), being used as a solvent, was purchased from Reanal 
(Hungary).  
 
Stock solutions of BQAC, ASP and DPPH (5 mM) were prepared in a polar solvent 
methanol and used for binary (ASP:DPPH, ASP:BQAC) and triple (ASP: BQAC:DPPC) 
model systems preparation. Corresponding volumes of the stock solutions were mixed to 
reach the molar ratio 1:10 of drugs to phospholipid. The mixtures were kept at room 
temperature for at least 10 min before the ESI analysis. The spraying procedure required 
dilution of the solutions to be studied to provide 250 μM final concentration of the 
components. It was proved in numerous studies [5–8] that utilization of methanol as a 
solvent improves significantly the quality of ESI mass spectra and does not disturb the 
composition of intermolecular complexes formed in the initial solutions [16].  
 
Mass spectral data were obtained in the positive ion mode, using triple quadruple (QqQ) 
Micromass Quattro Micro mass spectrometer («Waters», UK) which was equipped with 
the electrospray ion source. This source was operated in the standard ESI mode [5]. The 
potential of the spraying capillary was set at 3.5 kV. The cone voltage value of 10 V was 
used. ESI spectra were recorded in the mass range of 100–2000 Da. Data acquisition and 
processing were performed using MassLynx 4.1 software («Waters»).  
 
Results and discussion. To reveal the formation of intermolecular complexes of 
membranotropic drugs and membrane phospholipid DPPH, binary and triple mixtures of 
the compounds under study were examined by ESI mass spectrometry.  
 
At the initial stage of the study we have tested ASP: DPPH binary mixture with 1:10 
molar ratio of the components, whose ESI mass spectrum is presented in Fig. 1. The 
spectrum contains peaks of the individual components: ASP ⋅ Na+ (m/z 203.1),  
2ASP ⋅ Na+ (m/z 383.2) for ASP and DPPС ⋅ H+ (m/z 734.6), DPPС ⋅ Na+ (m/z 756.6), 
2DPPС ⋅ Na+ (m/z 1491) for DPPH. Note, that cationization by sodium ion is 
characteristic of the ESI procedure and correlates with ion-molecule interactions under 
natural conditions. The presence of the peak of a cationized noncovalent complex of 
aspirin with phospholipid molecule, DPPС ⋅ ASP ⋅ Na+ (m/z 936.5), proves the binding of 
aspirin to DPPH. It also testifies to the possibility of competition between aspirin and 
BQAC for the binding to the phospholipid molecular target.  
 
Note that aspirin binds with a single DPPH molecule only. This contrasts with the 
features of binding BQAC with DPPH in their binary mixtures, studied in our previous 
works [10, 12]. It was found that the diction (Cat2+) of BQAC can bind up to 9 DPPH 
molecules. Such supramolecular complexes, nDPPH ⋅ Cat2+, can be considered as a 
sufficient model of complexes BQAC with phospholipid membrane assemblies. 
Distinctions in the types of the complexes formed by aspirin and BQACs with DPPH are 
in correlation with the differences in mechanisms of their intermolecular interactions with 
phospholipids. While the dications of surface active BQACs are incorporated as 
components into phospholipid assemblies, the aspirin molecule, as it was shown in [15], 
interacts with the glycerol moiety of a separate DPPH molecule.  
 
At the next stage of the study, ESI mass spectra of equimolar mixtures of BQACs and 
aspirin were examined (Fig. 2). The abundant peak of noncovalent associate of a BQAC 
dication and acetylsalicylic acid anion – Cat2+ ⋅ (ASP-H)– – was observed at m/z 801.6 for 
decamethoxinum (Fig. 2, A), at m/z 693.5 for ethonium (Fig. 2, B), and at m/z 753.6 for 
thionium, along with the ions characteristic of individual components (Cat2+ and 
Cat2+⋅ Cl– for BQACs, ASP ⋅ Na+ and 2ASP ⋅ Na+ for ASP). This result pointed to one 
more possible mechanism of the BQAC-based drugs action modulation by aspirin, based 
on the formation of stable pair complexes between the BQAC dication and the organic 
acid anion, which deactivated the ionic forms of the medications. Note, that no definite 
information can be obtained as to a possibility of the formation of triple complexes  
Cat2+ ⋅ 2(ASP-H)–, since they are neutral and thus undetectable by mass spectrometry.   
 
Finally, the triple systems BQAC:ASP:DPPC (1:1:10 molar ratio) were probed (Fig. 3).  
 
The intermolecular complexes recorded in the mass spectra reflected the complexity of 
specific noncovalent interactions in the model systems. Firstly, the supramolecular 
complexes of the BQAC dication with up to 4 DPPC molecules were formed similarly to 
the drugphospholipid associates in their binary systems [10, 12]. Secondly, aspirin bound 
to a single DPPH molecule similarly to its behaviour in the binary system (Fig. 1). 
Thirdly, the dication-anion Cat2+⋅ (ASP-H)– complexes observed in the binary 
BQAC:ASP mixtures (Fig. 2) are formed in the triple system as well. The peaks 
distribution in the mass spectra pointed to the existence of a competition between BQACs 
and ASP for binding to DPPC molecules in the three systems, since abundances of the 
peaks of nDPPС ⋅ Cat2+ complexes, Cat2+⋅ (ASPH)– and DPPС ⋅ ASP ⋅ Na+ associates 
were of comparable intensities. The competition for binding ionic forms of the drugs to 
DPPH molecules and the formation of dication- anion complexes, revealed on the basis 
of mass spectrometric data, can be considered as molecular mechanisms of the possible 
drugs activity modulation.  
 
The effects observed at the molecular level were further verified at the level of model 
biomembranes. To prove the incorporation of the membranotropic agents into DPPC 
membranes and to evaluate their combined effect, DSC measurements [13] were carried 
out along with the mass spectrometric experiments. The results of the DSC study of the 
binary BQAC:DPPC, ASP:DPPC and triple BQAC:ASP:DPPC systems have shown that 
doping of the hydrated DPPH bilayer by individual BQAC, aspirin [13] or gentinsic acid 
[11, 17] decreased the temperature of phase transition in the membrane, that evidenced 
the disordering effect in the membrane. At the same time simultaneous addition of both 
BQAC and acidic agents did not cause substantial membrane disordering, which was 
interpreted as a confirmation of deactivation (modulation) of the drugs action.  
 
The effect of competitive intermolecular interactions observed at the level of 
biomolecules and model phospholipid biomembranes permits to formulate a task for 
further tests of the biological activity modulation for BQAC and acidic membranotropic 
agents as to their combined use at the level of microbial cells.  
 
Conclusions. The results of the ESI mass spectrometric study demonstrate the 
competitive complexation in the model systems containing the BQAC, aspirin and 
membrane DPPH phospholipids. The observed phenomenon testifies to the possibility of 
modulation of the activity of membranotropic BQAC-based antimicrobial agents and 
aspirin under their combined usage via several scenarios: due to either the competition 
between these two types of drugs for binding to the target phospholipid molecules, or the 
formation of stable pair noncovalent complexes between BQAC and aspirin ions. Owing 
to these competitive complexations, the activity of the both agents at their combined use 
can be much lower than the activity of each single agent. Thus, the mechanisms of the 
possible drug activity modulation are demonstrated experimentally on the model 
molecular level systems.  
 
The supposed modulation effect should be further inquired at the microbial cell level.  
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Scheme. Structures of the objects of investigation: I – decamethoxinum (monoisotopic 
molecular mass 692.5 Da); II – ethonium (584.4 Da); III – thionium (644.5 Da);  
IV – acetylsalicylic acid (180.0 Da); V – dipalmitoylphosphatidylcholine (733.6 Da)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. ESI mass spectrum of a binary mixture of aspirin (ASP) and DPPH phospholipid 
in molar ratio 1:10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. ESI mass spectra of equimolar mixtures of decamethoxinum with aspirin (A) and 
ethonium with aspirin (B)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. ESI mass spectra of triple BQAC:ASP:DPPC systems: A – BQAC is 
decamethoxinum; B – BQAC is ethonium; C – BQAC is thionium. Sets of peaks 
corresponding to [Cat ⋅ nDPPC]2+ complexes (n = 1 ÷ 4) are marked by (•) symbol     
 
